| Date | Title | Description | Source |
| 25.09.2020 | Recognition for Swiss innovation |
The first accolades were bestowed onto two personalities for their achievements.
Women in Databas... | startuptic... |
| 25.09.2020 | Recognition for Swiss innovation | The first accolades were bestowed onto two personalities for their achievements.
Women in Database ... | startuptic... |
| 03.08.2020 | Female entrepreneurs in the spotlight | As part of its ambition to achieve gender parity, the European Commission launched the EU Prize for ... | startuptic... |
| 03.08.2020 | Female entrepreneurs in the spotlight |
As part of its ambition to achieve gender parity, the European Commission launched the EU Prize fo... | startuptic... |
| 16.07.2019 | Amal Therapeutics becomes a subsidiary of a German Pharma gi... |
Two months following the announcement of their collaboration, Boehringer Ingelheim has acquired al... | startuptic... |
| 16.07.2019 | Boehringer Ingelheim to acquire Swiss cancer vaccine develop... | Amal’s lead product candidate is ATP128, a therapeutic cancer vaccine that has been in preclinical d... | medcitynew... |
| 03.05.2019 | AMAL Therapeutics enters clinical collaboration with Boehrin... |
AMAL Therapeutic’s lead candidate ATP128, is a chimeric recombinant protein designed using AMAL’s ... | startuptic... |
| 12.11.2018 | AMAL Therapeutics raises over CHF 33 million! | AMAL Therapeutics raises over CHF 33 million! 12.11.2018 10:35, Charlotte Pichon linkedIn facebook t... | venturelab... |
| 12.11.2018 | AMAL Therapeutics raises over CHF 33 million! | What is AMAL Therapeutics and how did you first get started working on therapeutic vaccines?
AMAL T... | venturekic... |
| 12.11.2018 | AMAL Therapeutics finalises CHF 33 million Series B round |
The Company will use the funds to progress its lead vaccine (ATP128) toward clinical development a... | startuptic... |
| 12.11.2018 | Amal Therapeutics Closes €29M in Series B Funding | Amal Therapeutics, a Geneva, Switzerland-based biotech developing peptide-based therapeutic cancer v... | finsmes.co... |
| 19.06.2018 | Un premier IPO Day lausannois couronné de succès |
Rassembler des scale-up suisses avec des banquiers d'affaires et des experts en investissement aut... | startuptic... |
| 18.05.2018 | First IPO Day in Lausanne on the horizon |
IPOs of Swiss tech companies from the life sciences as well as from ICT have become routine in the... | startuptic... |
| 10.11.2017 | "An IPO has become a serious alternative” |
IPO Day takes place the first time. Why at this precise moment?
There are a few reasons for that.... | startuptic... |
| 06.09.2017 | Amal Therapeutics Raises €8M in First Closing of Series B Fu... | Amal Therapeutics, a Geneva, Switzerland-based biotech startup developing novel, peptide-based thera... | finsmes.co... |
| 05.09.2017 | AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in F... | Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment F... | 3bfuturehe... |
| 05.09.2017 | AMAL Therapeutics raises CHF 8.8 million in first closing of... | AMAL Therapeutics raises CHF 8.8 million in first closing of Series B financing round 05.09.2017 11:... | venturelab... |
| 05.09.2017 | Cancer vax biotech Amal grabs $10M round; Global Blood The... | ⇨ Geneva-based Amal Therapeutics has picked up about $10 million in Series B money for its wo... | endpts.com... |
| 05.09.2017 | AMAL Therapeutics raises CHF 8.8 million in first closing of... | The Company will use the funds to progress its lead vaccine (ATP128) towards clinical studies and pr... | venturekic... |
| 05.09.2017 | AMAL Therapeutics raises CHF 8.8 million in Series B round |
In the first closing of a Series B Financing round AMAL Therapeutics (AMAL) has raised Euros 8 mil... | startuptic... |
| 14.09.2016 | Top 100 Swiss startups have been revealed |
Every year, distinguished 100 experts from various industries nominate their favourite startups of... | startuptic... |
| 30.03.2016 | Amal Therapeutics raises CHF 3 million in a Series A financi... | Amal Therapeutics raises CHF 3 million in a Series A financing round led by Boehringer Ingelheim Ven... | venturelab... |
| 30.03.2016 | Daily funding roundup - March 30, 2016 | Zavante closed $45M Series A funding; MapD secured $10M; Invoca closed $30M Series D funding
Invoca... | vator.tv/n... |
| 30.03.2016 | Amal Therapeutics raises CHF 3 million in a Series A financi... |
Amal Therapeutics is a Swiss biotech company developing and progressing therapeutic cancer vaccine... | startuptic... |
| 30.03.2016 | Amal Therapeutics Raises CHF3M in Series A Funding | Amal Therapeutics, a Geneva, Switzerland-based biotech company, completed a CHF 3m (€2.75m) in Serie... | finsmes.co... |
| 30.03.2016 | Amal Therapeutics raises CHF 3 million in a Series A financi... | Amal Therapeutics is a Swiss biotech company developing and progressing therapeutic cancer vaccines.... | venturekic... |
| 24.03.2016 | Amal Therapeutics receives CTI grant |
The CTI project, established in collaboration with the laboratory of Tumour Immunology of Dr. Paul... | startuptic... |
| 06.11.2015 | 11 start-ups selected for Swiss Venture Day Romandie |
The 4th Swiss Venture Day Romandie will take place on 18 November at EPFL. There will be eight reg... | startuptic... |
| 15.09.2015 | Amal Therapeutics and Oslo University Hospital announce rese... |
Amal Therapeutics, a Geneva based start-up Biotech Company announced today that it signed research... | startuptic... |
| 28.08.2015 | Start-ups selected for the 50th Swiss Venture Day |
Swiss Venture Day has once again gathered promising companies from very diverse industries; the sp... | startuptic... |
| 23.07.2015 | Amal Therapeutics publishes R&D findings in Cancer Resea... | Amal Therapeutics publishes R&D findings in Cancer Research 23.07.2015 17:00, Lara Rossi linkedI... | venturelab... |
| 23.07.2015 | Amal Therapeutics publishes R&D findings in Cancer Resea... | The publication underlines the value of a novel immunotherapy class able to simultaneously inducing ... | venturekic... |
| 29.06.2015 | Amal achieves proof of concept |
Amal Therapeutics announced today that part of its recent research findings about a new type of re... | startuptic... |
| 17.04.2015 | Nine hot start-ups, 400 visitors and Joe Jimenez |
Biotech is evolving into a mature industry – this is one of the results of the new Swiss Biotech R... | startuptic... |
| 26.11.2014 | Four new CTI Start-up label companies |
Two biotech-companies, an IT / cleantech start-up and a B2B software company are the new holders o... | startuptic... |
| 24.07.2014 | € 1.07 million grant to Amal Therapeutics and TransCure bioS... |
GBM is one of the most aggressive malignant primary brain tumors in humans with incidence of 2-3 c... | startuptic... |
| 09.07.2014 | Amal Therapeutics SA announces appointment of Johanna Hollda... |
Dr. Holldack has worked in the pharmaceutical industry for more than 20 years, where she has held ... | startuptic... |
| 25.03.2014 | Amal Therapeutics, un exemple de recherche de Seed financing... |
La co-fondatrice et CEO d'Amal Therapeutics était présente la semaine dernière au BioMed Up au Cam... | startuptic... |
| 17.03.2014 | A rich pitching event in Western Switzerland at BioMed Up in... |
One of the objectives of the BioMed Up Day hosted by A3 Angels and held at the Biotech Campus in G... | startuptic... |
| 04.03.2014 | 10 companies selected for Life Sciences Start-up Day |
The goal of the Life Sciences Start-up Day is to bring together business angels, investors, start-... | startuptic... |
| 21.02.2014 | Amal Therapeutics Raises Seed Funding | Amal Therapeutics SA, a Geneva, Switzerland and Berlin, Germany-based company focusing on the develo... | finsmes.co... |
| 20.02.2014 | Amal Therapeutics SA raises seed round from Boehringer Ingel... |
Amal Therapeutics was founded in 2012 as a spin-off of the University of Geneva. The company is de... | startuptic... |
| 09.07.2013 | Volkswirtschaftsstiftung supports 3db Technologies, Amal The... |
Smart vehicle keys are convenient but insecure. 3db Technologies aims to change this. And vehicle ... | startuptic... |
| 24.03.2013 | 7 Regular and 2 Elevator Pitches at the Swiss Venture Day - ... |
The Venture Day takes place at the SIX Swiss Exchange, Zurich, on 26 March in the afternoon. Regis... | startuptic... |
| 15.03.2013 | Companies for next Swiss Venture Day selected |
Like last time, again seven promising young companies have been selected today by the Board of CTI... | startuptic... |
| - | AMAL Therapeutics raises €8 million (CHF 8.8 million) in fir... | - | helsinninv... |
| - | Amal Therapeutics raises CHF 3 million in a Series A financi... | March 30, 2016
Amal Therapeutics (Amal) completes CHF 3 million (EUR 2.75 million) Series A financi... | htgf.de/en... |
| - | Boehringer Ingelheim to acquire Swiss cancer vaccine develop... | A large family-owned drugmaker in Germany plans to shell out more than $350 million to buy a cancer ... | medcitynew... |
| - | AMAL Therapeutics finalises €29 million (CHF 33.2 million) S... | November 12, 2018
AMAL Therapeutics SA (AMAL), a Swiss biotech developing peptide-based therapeut... | htgf.de/en... |
